Mereo BioPharma Posts $800,000 in Q3 Revenue and $0.01 Loss Per Share

John Kim

1 min read

Add as a preferred source on Google

Mereo BioPharma Posts $800,000 in Q3 Revenue and $0.01 Loss Per Share

The quarter ended Sept. 30, 2026, and the reported loss was basic and diluted.

By John Kim

Published Nov 10, 2026, 4:31 AM EST

A glass vial casts a sharp shadow beside a closed report volume / TokenPost.ai

Mereo BioPharma Group plc posted $800,000 in revenue and a $0.01 basic and diluted loss per share for the third quarter of 2026, covering the period ended Sept. 30.

The per-share loss was reported under U.S. GAAP. Mereo issued the quarterly results Nov. 9, 2026.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.